Inactivation of the Hepatic Cytochrome P450 System by Conditional Deletion of Hepatic Cytochrome P450 Reductase
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Cytochrome P450 (CYP) monooxygenases catalyze the oxidation of a large number of endogenous compounds and the majority of ingested environmental chemicals, leading to their elimination and often to their metabolic activation to toxic products. This enzyme system therefore provides our primary defense against xenobiotics and is a major determinant in the therapeutic efficacy of pharmacological agents. To evaluate the importance of hepatic P450s in normal homeostasis, drug pharmacology, and chemical toxicity, we have conditionally deleted the essential electron transfer protein, NADH:ferrihemoprotein reductase (EC, cytochrome P450 reductase, CPR) in the liver, resulting in essentially complete ablation of hepatic microsomal P450 activity. Hepatic CPR-null mice could no longer break down cholesterol because of their inability to produce bile acids, and whereas hepatic lipid levels were significantly increased, circulating levels of cholesterol and triglycerides were severely reduced. Loss of hepatic P450 activity resulted in a 5-fold increase in P450 protein, indicating the existence of a negative feedback pathway regulating P450 expression. Profound changes in the in vivo metabolism of pentobarbital and acetaminophen indicated that extrahepatic metabolism does not play a major role in the disposition of these compounds. Hepatic CPR-null mice developed normally and were able to breed, indicating that hepatic microsomal P450-mediated steroid hormone metabolism is not essential for fertility, demonstrating that a major evolutionary role for hepatic P450s is to protect mammals from their environment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, these mice had hepatomegaly, accumulated hepatic lipids, and had a 99% decrease in bile acids, 65% decrease in serum cholesterol, and 50% decrease in serum triglycerides.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [312]
In the citing paper
“By contrast, liver-specific POR knockout mice created by cre/lox technology were grossly normal-developing, growing, and living as long as normal mice, and having normal reproductive capacity, indicating normal gonadal P450 function (312,313).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [312]
In the citing paper
“Furthermore these animals had dramatically decreased capacities to metabolize acetaminophen, phenobarbital, and testosterone despite having a 5-fold increase in total hepatic P450 content.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [312]
In the citing paper
“Liver-specific knockout of POR in mice decreases the activities of hepatic drug-metabolizing enzymes (312, 313), thereby potentially rendering some drugs teratogenic.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [312]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature
Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199602000-00002 · Cited by 2,945
Conney, A. H. (1982) · PubMed · Cited by 1,557
Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302
Self-citationHayhurst, G. P., Lee, Y.-H., Lambert, G., Ward, J. M., & Gonzalez, F. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1393-1403.2001 · Cited by 1,107
Shimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., & Goldstein, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118951 · Cited by 816
The Role of Orphan Nuclear Receptors in the Regulation of Cholesterol Homeostasis
Repa, J. J., & Mangelsdorf, D. J. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.459 · Cited by 759
Role of CYP2E1 in the Hepatotoxicity of Acetaminophen
Lee, S. S. T., Buters, J. T. M., Pineau, T., Fernandez-Salguero, P., & Gonzalez, F. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.12063 · Cited by 656
Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat
Spady, D. K., & Dietschy, J. M. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37999-2 · Cited by 411
Research works printed but not linked: 4
- Pikuleva, 1999, Mol. Aspects Med., 20, 33
- Henderson, 1992, 10, 221
- Hines, 2001, Drug Metab. Dispos., 29, 623
- Conney, 1982, Cancer Res., 42, 4875
Cited by
Items 101–200 of 257
Wang, X., Zhao, X., Li, D., Lou, Y., Lin, Z., & Zhang, G. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1702 · Cited by 40
Characterizing Proteins of Unknown Function: Orphan Cytochrome P450 Enzymes as a Paradigm
Guengerich, F. P., Tang, Z., Salamanca-Pinzon, S. G., & Cheng, Q. (2010) · Molecular Interventions · doi:10.1124/mi.10.3.6 · Cited by 45
Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models
Jiang, X.-L., Gonzalez, F. J., & Yu, A. (2010) · Drug Metabolism Reviews · doi:10.3109/03602532.2010.512294 · Cited by 41
“…enzyme, transporter, or xenobiotic receptors in drug metabolism and disposition at the systemic level (Gonzalez, 2003; Gonzalez and Kimura, 2003; Henderson et al., 2003b; Henderson and Wolf, 2003; Dai and Wan, 2005; Xia et al., 2007; Muruganandan and Sinal, 2008; Lagas et al., 2009; Ou et al.,…”
BackgroundMethodMcLaughlin, L. A., Dickmann, L. J., Wolf, C. R., & Henderson, C. J. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021261 · Cited by 44
“Competent E. coli JM109 or DH5 cells were cotransformed with an individual P450 and pJR7, a plasmid which expresses human POR (Blake et al., 1996; Pritchard et al., 1997; Pritchard et al., 1998).”
BackgroundSelf-citationGray, J. P., Mishin, V. M., Heck, D. E., Laskin, D. L., & Laskin, J. D. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.05.015 · Cited by 39
“These findings are significant since this can result in inhibition of all cytochrome P450 enzymes, a process that may limit drug metabolism (Henderson et al., 2003).”
BackgroundInfluentialArlt, V. M., Poirier, M. C., Sykes, S. E., John, K., Moserová, M., Stiborová, M., Wolf, C. R., Henderson, C. J., & Phillips, D. H. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.06.016 · Cited by 38
“In HRN mice P450 oxidoreductase (Por), the electron donor to P450s, is deleted specifically in hepatocytes, resulting in the loss of essentially all hepatic P450 function (Henderson et al., 2003); we found that the levels of dG-N 2 -BPDE in livers of these mice treated intraperitoneally with BaP were higher than in WT…”
InfluentialSelf-citationBueters, R., Bael, A., Gasthuys, E., Chen, C. L., Schreuder, M. F., & Frazier, K. S. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.089755 · Cited by 40
“The importance of this enzyme is apparent because of observed embryonic lethality in knockout mice around day 8 to 9 (Shen et al., 2002; Henderson et al., 2003).”
BackgroundThe hepatic cytochrome P450 reductase null mouse as a tool to identify a successful candidate entity
Henderson, C. J., Pass, G. J., & Wolf, C. R. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2005.10.016 · Cited by 39
Self-citationPandey, A. V., Flück, C. E., Huang, N., Tajima, T., Fujieda, K., & Miller, W. L. (2004) · Endocrine Research · doi:10.1081/erc-200044134 · Cited by 39
Multigene Predictors of Tacrolimus Exposure in Kidney Transplant Recipients
Pulk, R., Schladt, D. P., Oetting, W. S., Guan, W., Israni, A. K., Matas, A. J., Remmel, R. P., Jacobson, P. A., & for the DeKAF Investigators (2015) · Pharmacogenomics · doi:10.2217/pgs.15.42 · Cited by 39
Fang, C., & Zhang, Q. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167742 · Cited by 35
“Several tissuespecific Cpr-null mouse models have been generated in recent years (Gu et al., 2003; Henderson et al., 2003; Weng et al., 2007; Fang et al., 2008b; Zhang et al., 2009), for studies on P450 functions in specific organs.”
BackgroundPharmacogenetics of P450 oxidoreductase: implications in drug metabolism and therapy
Hu, L., Zhuo, W., He, Y., Zhou, H., & Fan, L. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328358d92b · Cited by 40
Elens, L., Sombogaard, F., Hesselink, D. A., van Schaik, R. H. N., & van Gelder, T. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000001 · Cited by 37
Finn, R. D., McLaren, A. W., Carrie, D., Henderson, C. J., & Wolf, C. R. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121780 · Cited by 35
“Por floxed mice (Porlox/lox) were generated as described previously (Henderson et al., 2003a).”
BackgroundMethodSelf-citationWang, K., Peng, X., Zuo, Y., Li, Y., & Chen, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154633 · Cited by 35
“Conditional deletion of CPR in the liver results in the inactivation of the hepatic P450 system [21].”
BackgroundDobrinas, M., Cornuz, J., Pedrido, L., & Eap, C. B. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834e9e1a · Cited by 32
Jan, Y.-H., Richardson, J. R., Baker, A. A., Mishin, V. M., Heck, D. E., Laskin, D. L., & Laskin, J. D. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.07.023 · Cited by 34
“For example, liver specific deletion or conditional hepatic knockout of CPR decreases liver CYP activity and suppresses metabolism of a number of drugs and toxins including pentobarbital and acetaminophen (Gu et al., 2003; Henderson et al., 2003; Riddick et al., 2013).”
BackgroundFaouzi, S., Medzihradszky, K. F., Hefner, C. A., Maher, J. J., & Correia, M. A. (2007) · Biochemistry · doi:10.1021/bi700340n · Cited by 37
“(iv) A marked increase in CYP3A10/11 content is observed after conditional deletion of hepatic P450 reductase in mice (47).”
BackgroundMcCammon, K. M., Panda, S. P., Xia, C., Kim, J.-J. P., Moutinho, D., Kranendonk, M., Auchus, R. J., Lafer, E. M., Ghosh, D., Martasek, P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.716019 · Cited by 33
The role of vertebrate models in understanding craniosynostosis
Holmes, G. (2012) · Child s Nervous System · doi:10.1007/s00381-012-1844-3 · Cited by 33
“Recql4tm1Glu Baller–Gerold RECQL4 [124] opb(1), opb(2) Carpenter RAB23 [48, 49, 125] Por Antley–Bixler POR [126] Il11ra Craniosynostosis and dental anomalies IL11RA [127] 1474 Childs Nerv Syst (2012) 28:1471–1481”
History of Adrenal Research: From Ancient Anatomy to Contemporary Molecular Biology
Miller, W. L., & White, P. C. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac019 · Cited by 35
Henderson, C. J., McLaughlin, L. A., Finn, R. D., Ronseaux, S., Kapelyukh, Y., & Wolf, C. R. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055277 · Cited by 32
“This has been supported by experiments using hepatic cytochrome P450 reductase null (HRN) mice, which are essentially devoid of hepatic P450mediated drug metabolism; in this model, significant rates of metabolism for many drugs can still be observed in vivo (Henderson et al., 2003; Pass et al., 2005; Gu et al., 2007).”
InfluentialSelf-citationReed, L., Mrízová, I., Bárta, F., Indra, R., Moserová, M., Kopka, K., Schmeiser, H. H., Wolf, C. R., Henderson, C. J., Stiborová, M., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2162-7 · Cited by 32
“HRN mice have a deletion in their hepatocytes of P450 oxidoreductase (POR), the predominant electron donor to P450 enzymes, specifically (Henderson et al. 2003).”
BackgroundSelf-citationStiborová, M., Černá, V., Moserová, M., Mrízová, I., Arlt, V. M., & Frei, E. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms16010284 · Cited by 32
“[62] to evaluate the role of both hepatic POR and CYPs in xenobiotic metabolism.”
BackgroundElectron Transfer Pathways in Cholesterol Synthesis
Porter, T. D. (2015) · Lipids · doi:10.1007/s11745-015-4065-1 · Cited by 34
“Two groups reported the liver-specific (conditional) deletion of the cytochrome P450 reductase gene in 2003 [22, 23].”
BackgroundMagnetic field effects as a result of the radical pair mechanism are unlikely in redox enzymes
Messiha, H. L., Wongnate, T., Chaiyen, P., Jones, A. R., & Scrutton, N. S. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.1155 · Cited by 34
The Disruption of Hepatic Cytochrome P450 Reductase Alters Mouse Lipid Metabolism
Mutch, D. M., Klocke, B., Morrison, P., Murray, C. A., Henderson, C. J., Seifert, M., & Williamson, G. (2007) · Journal of Proteome Research · doi:10.1021/pr0700448 · Cited by 31
Self-citationMiller, W. L. (2012) · Science Signaling · doi:10.1126/scisignal.2003318 · Cited by 36
Kim, S., Wang, Y., Nabavi, N., Liu, Y., & Correia, M. A. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1195403 · Cited by 36
“Accordingly, genetic deletion of cytochrome P450 reductase (CPR), the sine qua non P450 redox partner, and consequent abolition of P450 oxidative function indeed results in the elevation of P450 hepatic content, most likely via protein stabilization (Gu et al., 2003; Henderson et al., 2003).”
BackgroundDuarte, M. P., Palma, B. B., Gilep, A. A., Laires, A., Oliveira, J. S., Usanov, S. A., Rueff, J., & Kranendonk, M. (2005) · Mutagenesis · doi:10.1093/mutage/gei012 · Cited by 31
“Cytochrome P540 (CYP) enzymes catalyze the oxidation of a large number of endogenous compounds, constitute a major determinant of the half-life and pharmacological properties of therapeutic drugs and are involved in the bioactivation of many drugs, toxins and carcinogens to their ultimate reactive species (1).”
BackgroundCytochromes P450—A Family of Proteins and Scientists–Understanding their Relationships
Masters, B. S. S., & Marohnic, C. C. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600570065 · Cited by 35
“Henderson et al. (2003) and Wu et al. (2003) independently reported on hepatic CYPOR null mice created using the CrelloxP system, as a means of studying the contribution of liver P450s to xenobiotic and cholesterol metabolism, while avoiding the embryonic lethality that was observed by Shen et al. (2002) in the global…”
MethodAlqahtani, S., Bukhari, I. A., Albassam, A. A., & Alenazi, M. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1482277 · Cited by 31
Defective bile salt biosynthesis and hydroxylation in mice with reduced cytochrome P450 activity
Kunne, C., Acco, A., Hohenester, S. D., Duijst, S., de Waart, D. R., Zamanbin, A., & Elferink, R. P. J. O. (2012) · Hepatology · doi:10.1002/hep.26133 · Cited by 30
“Also, livers of Hrn mice were enlarged (Table 1) and appeared to be fatty, as described by Henderson et al.3 Serum bilirubin was not increased (data not shown), indicating that there was no cholestasis.”
BackgroundMethodInfluentialStanley, L. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18657-8.00029-3 · Cited by 49
Stiborová, M., Frei, E., Arlt, V. M., & Schmeiser, H. H. (2013) · Xenobiotica · doi:10.3109/00498254.2013.848310 · Cited by 29
“This model was developed to evaluate the role of both hepatic Por and Cyps in xenobiotic metabolism (Henderson et al., 2003).”
MethodFang, C., Gu, J., Xie, F., Behr, M. J., Yang, W., Abel, E. D., & Ding, X. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021881 · Cited by 29
“Given the previously reported compensatory gene expression changes in the liver of the liver-Cpr-null mice (Gu et al., 2003; Henderson et al., 2003), we performed immunoblot analysis to detect potential compensatory increases in the levels of CPR-dependent enzymes, including P450 and HO, in the…”
MethodP450 Oxidoreductase Deficiency: A New Disorder of Steroidogenesis
Miller, W. L., Huang, N., Pandey, A. V., Flück, C. E., & Agrawal, V. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1336.012 · Cited by 37
Lentiviral-Mediated RNAi Knockdown Yields a Novel Mouse Model for Studying Cyp2b Function
Damiri, B., Holle, E., Yu, X., & Baldwin, W. S. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr309 · Cited by 30
“Examples include the hepatic POR-null mouse model (Henderson et al., 2003) and HNF4a-null mice (Hayhurst et al.”
BackgroundThe Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Overexpression of membrane proteins from higher eukaryotes in yeasts
Emmerstorfer‐Augustin, A., Wriessnegger, T., Hirz, M., & Pichler, H. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5948-4 · Cited by 28
“CYP450 activity is irrevocably linked to a finely balanced system of cofactor recycling, oxygen supply, correct integration of iron into the active site and perfect teamwork with the corresponding reductase that delivers electrons (Gu et al. 2003; Henderson et al. 2003; Omura 2010).”
Raghavendran, H. R. B. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i24.3829 · Cited by 26
“. This enzyme system, therefore, provides our primary defense against xenobiotics and is a major determinant in the therapeutic effi cacy of pharmacological agents [ 20 ]”
BackgroundGu, J., Chen, C.-S., Wei, Y., Fang, C., Xie, F., Kannan, K., Yang, W., Waxman, D. J., & Ding, X. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.118240 · Cited by 28
New insights into the role of cytochrome P450 reductase (POR) in microsomal redox biology
Porter, T. D. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.02.002 · Cited by 24
Potęga, A., Dabrowska, E., Niemira, M., Kot‐Wasik, A., Ronseaux, S., Henderson, C. J., Wolf, C. R., & Mazerska, Z. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.038984 · Cited by 24
“The generation of hepatic reductase null (HRN) mice has been described previously (Henderson et al., 2003).”
BackgroundMethodSelf-citationPorter, T. D., Banerjee, S., Stolarczyk, E. I., & Zou, L. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.038562 · Cited by 26
“This pattern of lipidosis closely resembles that observed in hepatocytes of hepatic POR-null mice (Gu et al., 2003; Henderson et al., 2003).”
BackgroundRona, L. D. P., de Carvalho-Pinto, C. J., & Peixoto, A. A. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-33 · Cited by 23
“Previous studies have shown that the cytochrome P450 gene family, which is involved in metabolic insecticide resistance, requires CPR to function [19,20].”
BackgroundLiao, M., Zgoda, V. G., Murray, B. P., & Correia, M. A. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009654 · Cited by 25
“oxidative uncoupling through disruption of their prosthetic heme reduction (Henderson et al., 2003; Zhukov and Ingelman-Sundberg, 1999) or quasi-irreversible complexation of the P450 heme (Watkins et al.”
BackgroundHou, X., Zhou, J., Yu, S., Zhou, L., Zhang, Y., Zhong, D., & Chen, X. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.081182 · Cited by 22
“Meanwhile, POR can directly mediate the one-electron reductive biotransformation, such as the nitro reduction of aristolochic acid (Henderson et al., 2003; Stiborová et al., 2005, 2011).”
BackgroundAguilar, A., Wu, S., & De Luca, F. (2009) · Endocrinology · doi:10.1210/en.2009-0043 · Cited by 21
“cally normal mice (45), suggesting that the skeletal abnormalities of Por knockout mice (and, possibly, of patients with POR mutations) do not depend from the decreased activity of a hepatic enzyme such as CYP26A1.”
BackgroundDeletion of 30 Murine Cytochrome P450 Genes Results In Viable Mice With Compromised Drug Metabolism
Scheer, N., McLaughlin, L. A., Rode, A., MacLeod, A. K., Henderson, C. J., & Wolf, C. R. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.057885 · Cited by 21
“However, in a number of previous gene deletions—the hepatic P450 reductase null (HRN) and cytochrome b5 null (BCN) models (Henderson et al., 2003; TABLE 1 Pharmacokinetic parameters for drug cocktail administered to WT and Cyp2c/2d/3a KO mice A five-drug cocktail was administered to WT (n = 5),…”
MethodSelf-citationTuresky, R. J., Konorev, D., Fan, X., Tang, Y., Yao, L., Ding, X., Xie, F., Zhu, Y., & Zhang, Q.-Y. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00405 · Cited by 21
Kondrová, E., Stopka, P., & Souček, P. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.11.002 · Cited by 21
“It has been shown that mice lacking hepatic P450 activity displayed alterations in lipid and cholesterol metabolism and their capacity to metabolize selected xenobiotics was severely impaired (Henderson et al., 2003).”
BackgroundCorreia, M. A., & Liao, M. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.1.33 · Cited by 22
Heintze, T., Klein, K., Hofmann, U., & Zanger, U. M. (2021) · Scientific Reports · doi:10.1038/s41598-020-79952-1 · Cited by 23
Sakamoto, Y., Inoue, K., Takahashi, M., Taketa, Y., Kodama, Y., Nemoto, K., Degawa, M., Gamou, T., Ozawa, S., Nishikawa, A., et al. (2013) · Toxicologic Pathology · doi:10.1177/0192623313482055 · Cited by 21
“The increased mRNA expression level of CYP reductase associated with liver hypertrophy observed in the present study reflected the activation of CYPs in the liver (Henderson et al. 2003).”
BackgroundDing, L., Li, L., Liu, S., Bao, X., Dickman, K. G., Sell, S., Mei, C., Zhang, Q.-Y., Gu, J., & Ding, X. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz225 · Cited by 21
“, 2005), the liver-specific Cpr-null (liver-Cpr-null) mice (fatty liver) (Gu et al., 2003; Henderson et al., 2003), and the intestinal epithelium-specific Cpr-null (IE-Cprnull) mice (hypersensitivity to ricin-induced intestinal damage) (Ahlawat et al.”
BackgroundComplete correction of murine phenylketonuria by selection-enhanced hepatocyte transplantation
Vonada, A., Wakefield, L., Martinez, M., Harding, C. O., Grompe, M., & Tiyaboonchai, A. (2023) · Hepatology · doi:10.1097/hep.0000000000000631 · Cited by 20
“Mice with a complete hepatic deficiency of Cypor [22,23] have been shown to develop and reproduce normally.”
BackgroundHe, C., Liang, J., Liu, S., Zeng, Y., Wang, S., Wu, Q., Xie, W., & Zhang, Y. (2019) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2019.07.018 · Cited by 19
Hepatic cytochrome P450 ubiquitination: Conformational phosphodegrons for E2/E3 recognition?
Correia, M. A., Wang, Y., Kim, S.-M., & Guan, S. (2014) · IUBMB Life · doi:10.1002/iub.1247 · Cited by 20
Novel SNPs in Cytochrome P450 Oxidoreductase
Hart, S. N., Li, Y., Nakamoto, K., Wesselman, C., & Zhong, X. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.322 · Cited by 20
Carlson, G. P. (2012) · Toxicology · doi:10.1016/j.tox.2012.02.006 · Cited by 18
Li, L., & Porter, T. D. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.02.010 · Cited by 19
“with the hepatic lipidosis characteristic of these mice [11,12].”
BackgroundGonzález-Lopez, M., Sealls, W., Jesch, E. D., Brosnan, M. J., Ladunga, I., Ding, X., Black, P. N., & Dirusso, C. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00209.2010 · Cited by 21
“Livers of LCN mice are steatotic when mice are reared on standard rodent chow (13, 16).”
InfluentialKucab, J. E., Phillips, D. H., & Arlt, V. M. (2012) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21679 · Cited by 19
“Two antibodies to Cyp1a1 [Henderson et al., 2003; Mizerovska et al., 2011] and one antibody to Cyp1b1 (CYP1B12-A, Alpha Diagnostic International, San Antonio, TX) were tested but unable to detect these proteins in HUF whole cell lysates.”
BackgroundNew Horizon of MDR1 (P-glycoprotein) Study
Mizutani, T., & Hattori, A. (2005) · Drug Metabolism Reviews · doi:10.1080/03602530500205358 · Cited by 18
“Total active hepatic CYPs in hepatic cytochrome P450 reductase null mice were increased almost fivefold, and this level appeared to be sustained until at least 12 months of age (Henderson et al., 2003a,b).”
BackgroundHeintze, T., Wilhelm, D., Schmidlin, T., Hofmann, U., Zanger, U. M., Schwab, M. G., & Klein, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.769703 · Cited by 19
“Alterations in PPARα target gene expression may be causative to a decrease in fatty acid oxidation but an increase in fatty acid uptake, which subsequently accounts for the severe hepatic lipidosis observed in mice and cell culture experiments (Gu et al., 2003; Henderson et al., 2003;Weng et al., 2005; Porter et al.,…”
BackgroundInfluentialUehara, S., Iida, Y., Ida-Tanaka, M., Goto, M., Kawai, K., Yamamoto, M., Higuchi, Y., Ito, S., Takahashi, R., Kamimura, H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-19242-0 · Cited by 17
Tomková, M., Marohnic, C. C., Gurwitz, D., Šeda, O., Masters, B. S. S., & Martásek, P. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.21 · Cited by 17
Arlt, V. M., Singh, R., Stiborová, M., da Costa, G. G., Frei, E., Evans, J. D., Farmer, P. B., Wolf, C. R., Henderson, C. J., & Phillips, D. H. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.041343 · Cited by 17
“In brief, Por floxed mice (Por) (Henderson et al., 2003) were crossed with a transgenic line expressing Cre recombinase under the control of the rat CYP1A1 promoter (Cre) (Ireland et al.”
BackgroundSelf-citationFélix, R. C., & Silveira, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024181 · Cited by 16
“Effect of CPR silencing in P450 cytochromes expression As CPR inhibition eliminates all microsomal P450 activity in the mouse model [22], the same approach was applied to evaluate whether P450 cytochromes have some role in controlling Plasmodium infection.”
MethodWei, Y., Zhou, X., Fang, C., Li, L., Kluetzman, K., Yang, W., Zhang, Q.-Y., & Ding, X. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167411 · Cited by 17
“The specific functions of hepatic CPR/P450 in cholesterol synthesis and homeostasis and in xenobiotic clearance were demonstrated through mouse models having a hepatocyte-specific Cpr deletion (Gu et al., 2003, Henderson et al., 2003).”
BackgroundCorrection: Quercetin Induces Hepatic Lipid Omega-Oxidation and Lowers Serum Lipid Levels in Mice
den Hil, E. F. H.-V., Keijer, J., Bunschoten, A., Vervoort, J. J. M., Staňková, B., Bekkenkamp‐Grovenstein, M., Herreman, L., Venema, D. P., Hollman, P. C. H., TVRZICKÁ, E., et al. (2013) · PLoS ONE · doi:10.1371/annotation/53e96376-38fe-40e7-b73a-60e7232cef0e · Cited by 16
Reed, L., Jarvis, I. W. H., Phillips, D. H., & Arlt, V. M. (2020) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2020.503162 · Cited by 15
Lee, J. W., Kim, Y., Yoon, S., & Lee, S. K. (2012) · Environmental Toxicology · doi:10.1002/tox.21833 · Cited by 15
“CPR is the obligatory electron donor for all microsomal CYP enzymes (Henderson et al., 2003).”
BackgroundPotential Biological Functions of Cytochrome P450 Reductase-dependent Enzymes in Small Intestine
D’Agostino, J., Ding, X., Zhang, P., Jia, K., Fang, C., Zhu, Y., Spink, D. C., & Zhang, Q.-Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.354274 · Cited by 16
“The influence of the liver on SI gene expression was highlighted in a study of the hepatic POR null mouse (7), in which many changes in gene expression were observed in the intestine (42).”
BackgroundInfluentialHenderson, C. J., McLaughlin, L. A., Osuna‐Cabello, M., Taylor, M., Gilbert, I. H., McLaren, A. W., & Wolf, C. R. (2014) · Biochemical Journal · doi:10.1042/bj20140582 · Cited by 15
Self-citationLiu, X., Xue, X., Gong, L., Qi, X., Wu, Y., Xing, G., Luan, Y., Xiao, Y., Wu, X., Li, Y., et al. (2011) · Metabolomics · doi:10.1007/s11306-011-0385-1 · Cited by 15
“We adopted a well-developed model, the liver-specific cytochrome P450 reductase (CPR) knockout (KO) mouse (Gu et al. 2003; Henderson et al. 2003), in which the CPR gene encoding for the sole electron donor for all microsomal CYPs was deleted specifically in the liver, resulting in a loss of hepatic…”
MethodLengler, J., Omann, M. R., Düvier, D., Holzmüller, H., Gregor, W., Salmons, B., Günzburg, W. H., & Renner, M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.012 · Cited by 15
Knockout Mice in Xenobiotic Metabolism
Henderson, C. J., Otto, D. M. E., McLaren, A. W., Carrie, D., & Wolf, C. R. (2003) · Drug Metabolism Reviews · doi:10.1081/dmr-120026869 · Cited by 15
Self-citationArlt, V. M., Henderson, C. J., Wolf, C. R., Stiborová, M., & Phillips, D. H. (2014) · Toxicology Research · doi:10.1039/c4tx00116h · Cited by 14
Self-citationMutch, D. M., Crespy, V., Clough, J., Henderson, C. J., Lariani, S., Mansourian, R., Moulin, J., Wolf, C. R., & Williamson, G. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00565.2005 · Cited by 14
“reduction of 90% in the production and secretion of bile acids (12), thereby enabling the influence of bile on the absorption of quercetin to be determined.”
InfluentialSelf-citationAscorbic acid reverses the prolonged anesthetic action of pentobarbital in Akr1a-knockout mice
Ito, J., Otsuki, N., Zhang, X., Konno, T., Kurahashi, T., Takahashi, M., Yamato, M., Matsuoka, Y., Yamada, K., Miyata, S., et al. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.12.004 · Cited by 13
Polusani, S. R., Kar, R., Riquelme, M. A., Masters, B. S. S., & Panda, S. P. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.132 · Cited by 14
“Although these mice (liver specific knock-out) grew normally and were fertile, they exhibited defective steroid and fatty acid metabolism and altered liver toxicity towards different drugs, which can be attributed to defects in CYPOR/CYP-mediated reactions [9,10].”
Aimová, D., Poljaková, J., Kotrbová, V., Moserová, M., Frei, E., Arlt, V. M., & Stiborová, M. (2008) · Interdisciplinary Toxicology · doi:10.2478/v10102-010-0033-z · Cited by 13
“Copyright © 2010 Slovak Toxicology Society SETOX To evaluate the contribution and importance of hepatic CYP enzymes to the activation of ellipticine and BaP in vivo, we have used in our former and present studies the rats and especially the HRNTM mice, lacking POR and thus also POR‐mediated CYP enzyme activity in the…”
MethodBiochemical analysis of mutations in P450 oxidoreductase
Pandey, A. V. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341186 · Cited by 14
Zhu, Y., Ding, X., Fang, C., & Zhang, Q.-Y. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.088914 · Cited by 12
Gao, L., Liu, F.-Q., Yang, L. P., Cheng, L. Z., Dai, H.-Y., Tao, R., Cao, S.-P., Wang, D., & Tang, J. (2016) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-016-2095-0 · Cited by 12
McMahon, M. J., Ding, S., Acosta-Jimenez, L., Terranova, R., Gérard, M.-A., Vitobello, A., Moggs, J. G., Henderson, C. J., & Wolf, C. R. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.113555 · Cited by 12
“Rabbit antibodies against: rat CYP2B1, CYP3A1 and CYP4A1 have been previously described, and have been shown to cross-react specifically with the corresponding murine P450 enzymes (Forrester et al., 1992; Henderson et al., 2003; Scheer et al., 2014).”
BackgroundSelf-citationIn vivo expansion of gene-targeted hepatocytes through transient inhibition of an essential gene
Giorgi, M. D., Park, S. H., Castoreno, A. B., Cao, M., Hurley, A. E., Saxena, L., Chuecos, M. A., Walkey, C. J., Doerfler, A. M., Furgurson, M. N., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adk3920 · Cited by 11
Lee, C., Ding, X., & Riddick, D. S. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.048835 · Cited by 12
“Both mouse strains showed a profound decrease in all hepatic microsomal P450 functions, a compensatory increased expression of several P450 proteins, reduced circulating levels of cholesterol and triglycerides, and hepatic lipidosis (Gu et al., 2003; Henderson et al., 2003).”
BackgroundAssessing cytochrome P450 function using genetically engineered mouse models
Hannon, S. L., & Ding, X. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2022.05.008 · Cited by 11
Wiśniewska, A., Niemira, M., Jagiełło, K., Potęga, A., Świst, M., Henderson, C. J., Skwarska, A., Augustin, E., Konopa, J., & Mazerska, Z. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.03.013 · Cited by 11
“The studies on C-1748 elimination in mice, where POR had been conditionally deleted in the liver (HRN) and in wild-type (WT) mice [21], were also performed.”
BackgroundMethodSelf-citationPawłowska, M., Augustin, E., & Mazerska, Z. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.132 · Cited by 11
Lee, C., Ding, X., & Riddick, D. S. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052993 · Cited by 10
“ABBREVIATIONS: ABT, 1-aminobenzotriazole; AHR, aryl hydrocarbon receptor; ANOVA, analysis of variance; CPR or POR, NADPH–cytochrome P450 oxidoreductase; DRE, dioxin-responsive element; FMO, flavin-containing monooxygenase; HAH, halogenated aromatic hydrocarbon; HRN, hepatic P450 reductase-null; LCN, liver Cpr-null; Lu…”
InfluentialVatsis, K. P., & Coon, M. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.167 · Cited by 10
Kunne, C., de Graaff, M., Duijst, S., de Waart, D. R., Elferink, R. P. J. O., & Paulusma, C. C. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.102 · Cited by 10
MOLECULAR MECHANISM OF GENOTOXICITY OF THE ENVIRONMENTAL POLLUTANT 3-NITROBENZANTHRONE
Stiborová, M., Arlt, V. M., Henderson, C. J., Wolf, C. R., Frei, E., Schmeiser, H. H., & Phillips, D. H. (2005) · Biomedical Papers · doi:10.5507/bp.2005.025 · Cited by 10
Self-citationŠilhavý, J., Mlejnek, P., Šimáková, M., Malínská, H., Marková, I., Hüttl, M., Miklánková, D., Kazdová, L., Vrbacký, M., Pecinová, A., et al. (2023) · Metabolites · doi:10.3390/metabo13020192 · Cited by 11
“These data suggest that the P450 system is a key regulator of hepatic lipid homoeostasis and liver growth [42].”
Background7-Dehydrocholesterol reductase activity is independent of cytochrome P450 reductase
Zou, L., Li, L., & Porter, T. D. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.06.011 · Cited by 9
“Indeed, the loss of POR expression severely impacts the activity of all known POR-dependent enzymes [7,11].”
BackgroundHan, J., Yee, J., Chung, J. E., Lee, K. E., Park, K., & Gwak, H. S. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1201 · Cited by 10
“The importance of the POR gene in drug metabolism was reported in a study using liver-specific knockout mice (Henderson et al., 2003).”
Background
Metadata
- Authors
- Henderson, C. J., Otto, D. M. E., Carrie, D., Magnuson, M. A., McLaren, A. W., Rosewell, I., & Wolf, C. R.
- Affiliations
- Cancer Research UK (GB)
- Corresponding author
- Rosewell, Ian
- Wolf, C. Roland
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-04
- Volume
- 278
- Issue
- 15
- Pages
- 13480-13486
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2047821701
- Semantic Scholar
- 23689d9cea73d2a1ad2d52b9778fe58ba7110680
- Cited by
- 258
- References
- 52
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 6 · 2019: 6 · 2018: 7 · 2017: 6 · 2016: 10 · 2015: 15 · 2014: 19 · 2013: 19 · 2012: 25
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6409 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- NADPH-cytochrome P450 reductase, conditional gene deletion, bile acid synthesis, cholesterol metabolism, acetaminophen metabolism, steroid hormone metabolism
- MeSH terms
- Acetaminophen, Animals, Cytochrome P-450 Enzyme System, Exons, Female, Glutathione, Liver, Male, Mice, Transgenic, NADPH-Ferrihemoprotein Reductase, Pentobarbital, Promoter Regions, Genetic, Serum Albumin, Sex Characteristics, Restriction Mapping, Genomic Library, Gene Deletion, Mice, Knockout, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.